Cargando…
Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Ticagrelor is believed to be a more potent and faster antiplatelet agent compared with clopidogrel and may result in lower ischemic outcomes in patients with acute coronary syndrome. However, the best strategy of switching from ticagrelor to clopidogrel is unclear. Current guidelines advocate clopid...
Autores principales: | Cakal, Sinem, Cakal, Beytullah, Güven, Zafer, Tosu, Aydın Rodi, Kalyoncuoglu, Muhsin, Biter, Halil Ibrahim, Apaydın, Ziya, Karaca, Ibrahim Oguz, Belen, Erdal, Can, Mehmet Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199609/ https://www.ncbi.nlm.nih.gov/pubmed/34199404 http://dx.doi.org/10.3390/jcm10112463 |
Ejemplares similares
-
Association of eosinophil-to-lymphocyte ratio with coronary slow-flow phenomenon in patients undergoing coronary angiography
por: Tosu, Aydın Rodi, et al.
Publicado: (2022) -
The effect of recanalization of a chronic total coronary occlusion on P-wave dispersion
por: Tosu, Aydın Rodi, et al.
Publicado: (2021) -
Predictive value of C-reactive protein/albumin ratio for no-reflow in patients with non-ST-elevation myocardial infarction
por: Rodi Tosu, Aydın, et al.
Publicado: (2022) -
Prognostic value of the TyG index for in-hospital mortality in nondiabetic COVID-19 patients with myocardial injury
por: Biter, Halil İbrahim, et al.
Publicado: (2022) -
Predicting One-Year Deaths and Major Adverse Vascular Events with the Controlling Nutritional Status Score in Elderly Patients with Non–ST-Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Kalyoncuoğlu, Muhsin, et al.
Publicado: (2021)